HLS Therapeutics (HLS) AGM 2025 summary

Opening remarks and agenda

• Meeting opened with a welcome and instructions for virtual participation, including Q&A and voting procedures.

• Forward-looking statements disclaimer was read, highlighting risks and uncertainties.

• Agenda included presentation of financial statements, election of directors, and reappointment of auditor.

Board and executive committee updates

• Officers and director nominees were introduced, including CEO, Corporate Secretary, and all director candidates.

Corporate governance

• Virtual-only format adopted to replicate in-person experience, with online voting and Q&A.

• Quorum confirmed and meeting declared duly constituted.

• Scrutineer appointed to oversee voting and attendance.